Your search returned 1590 results.

Results
	681.	A phase I and pharmacokinetic study of oral lapatinib administered once or twice daily in patients with solid malignancies. [electronic resource] by Burris, Howard A Taylor, Charles W Jones, Suzanne F Koch, Kevin M Versola, Melissa J Arya, Niki Fleming, Ronald A Smith, Deborah A Pandite, Lini Spector, Neil Wilding, George Producer: 20091229 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	682.	[Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?]. [electronic resource] by Gutierrez, Maya Lyazidi, Souad Brasseur, Louis Cvitkovic, Frédérique Le Scodan, Romuald Producer: 20110711 In: Bulletin du cancer vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	683.	Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy. [electronic resource] by Lemmens, Katrien Doggen, Kris De Keulenaer, Gilles W Producer: 20110526 In: American journal of physiology. Heart and circulatory physiology vol. 300 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	684.	Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization. [electronic resource] by Williams, Kevin P Allensworth, Jennifer L Ingram, Shalonda M Smith, Ginger R Aldrich, Amy J Sexton, Jonathan Z Devi, Gayathri R Producer: 20130916 In: Cancer letters vol. 337 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	685.	Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials. [electronic resource] by Perez, Edith A Koehler, Maria Byrne, Julie Preston, Alaknanda J Rappold, Erica Ewer, Michael S Producer: 20080624 In: Mayo Clinic proceedings vol. 83 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	686.	Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. [electronic resource] by Yun, Cai-Hong Boggon, Titus J Li, Yiqun Woo, Michele S Greulich, Heidi Meyerson, Matthew Eck, Michael J Producer: 20070430 In: Cancer cell vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	687.	First-line treatment for advanced pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. [electronic resource] by Oberstein, Paul E Saif, Muhammad Wasif Producer: 20110809 In: JOP : Journal of the pancreas vol. 12 Availability: No items available. Save to lists Add to cart (remove)
	688.	Targeted therapy for gastric cancer--current status. [electronic resource] by Kulig, Jan Kołodziejczyk, Piotr Kulig, Piotr Legutko, Janusz Producer: 20130821 In: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	689.	A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer. [electronic resource] by Janni, Wolfgang Sarosiek, Tomasz Karaszewska, Boguslawa Pikiel, Joanna Staroslawska, Elzbieta Potemski, Piotr Salat, Christoph Brain, Etienne Caglevic, Christian Briggs, Kathryn Desilvio, Michelle Marini, Luca Papadimitriou, Christos Producer: 20140919 In: Breast cancer research and treatment vol. 143 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	690.	Trastuzumab-induced recruitment of Csk-homologous kinase (CHK) to ErbB2 receptor is associated with ErbB2-Y1248 phosphorylation and ErbB2 degradation to mediate cell growth inhibition. [electronic resource] by Dokmanovic, Milos Wu, Yun Shen, Yi Chen, Jieqing Hirsch, Dianne S Wu, Wen Jin Producer: 20150603 In: Cancer biology & therapy vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	691.	A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2-directed therapy. [electronic resource] by Grellety, T Soubeyran, I Robert, J Bonnefoi, H Italiano, A Producer: 20160922 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	692.	Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review. [electronic resource] by Zhang, Xiao Zhang, Xin-Ji Zhang, Tian-Yi Yu, Fei-Fei Wei, Xin Li, Ye-Sheng He, Jia Producer: 20150601 In: BMC cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	693.	Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKt inhibitor MK2206 in mammary cancer models. [electronic resource] by Lubet, Ronald A Steele, Vernon E Juliana, M M Bode, Ann Moeinpour, Fariba Grubbs, Clinton J Producer: 20181102 In: Oncology reports vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	694.	microRNA-205 regulates HER3 in human breast cancer. [electronic resource] by Iorio, Marilena V Casalini, Patrizia Piovan, Claudia Di Leva, Gianpiero Merlo, Andrea Triulzi, Tiziana Ménard, Sylvie Croce, Carlo M Tagliabue, Elda Producer: 20090513 In: Cancer research vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	695.	Hepatotoxicity associated with lapatinib in an experimental rat model. [electronic resource] by Demirci, Umut Buyukberber, Suleyman Yılmaz, Guldal Kerem, Mustafa Coskun, Ugur Uner, Aytug Baykara, Meltem Pasaoglu, Hatice Pasali, Hatice Benekli, Mustafa Producer: 20120216 In: European journal of cancer (Oxford, England : 1990) vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	696.	HER2/neu may not be an interesting target in biliary cancers: results of an early phase II study with lapatinib. [electronic resource] by Peck, Joshua Wei, Lai Zalupski, Mark O'Neil, Bert Villalona Calero, Miguel Bekaii-Saab, Tanios Producer: 20120621 In: Oncology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	697.	Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen. [electronic resource] by Yardley, Denise A Hart, Lowell Bosserman, Linda Salleh, Mansoor N Waterhouse, David M Hagan, Maura K Richards, Paul DeSilvio, Michelle L Mahoney, Janine M Nagarwala, Yasir Producer: 20130725 In: Breast cancer research and treatment vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	698.	Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice. [electronic resource] by Sysa-Shah, Polina Xu, Yi Guo, Xin Belmonte, Frances Kang, Byunghak Bedja, Djahida Pin, Scott Tsuchiya, Noriko Gabrielson, Kathleen Producer: 20130423 In: PloS one vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	699.	Lentiviral vector-based insertional mutagenesis identifies genes involved in the resistance to targeted anticancer therapies. [electronic resource] by Ranzani, Marco Annunziato, Stefano Calabria, Andrea Brasca, Stefano Benedicenti, Fabrizio Gallina, Pierangela Naldini, Luigi Montini, Eugenio Producer: 20151022 In: Molecular therapy : the journal of the American Society of Gene Therapy vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	700.	Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer. [electronic resource] by Chan, Arlene Shannon, Catherine de Boer, Richard Baron-Hay, Sally Redfern, Andrew Bauwens, Astrid Craft, Paul Webb, Suzanne Townsend, Amanda Kotasek, Dusan Producer: 20150702 In: Asia-Pacific journal of clinical oncology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1590 results.